State FL
Clinical Trials in Florida
Recruiting clinical trials with at least one study location in Florida. Data updated daily from ClinicalTrials.gov.
Top Conditions in Florida
NCT06077942 N/A
Recruiting
FX Shoulder Solutions Retrospective / Prospective Clinical Study
Condition
Rotator Cuff Syndrome of Shoulder and Allied Disorders
Enrollment
600 pts
Location
United States
Sponsor
FX Shoulder Solutions
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
NCT06263322 N/A
Recruiting
The ROAMM-EHR Study
Condition
Peripheral Arterial Disease
Enrollment
50 pts
Location
United States
Sponsor
University of Florida
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
NCT07456696 Phase 3
Recruiting
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (...
Condition
Post Traumatic Stress Disorder
Enrollment
300 pts
Location
United States
Sponsor
Transcend Therapeutics
NCT06211062 Phase 2
Recruiting
The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fati...
Condition
ME/CFS
Enrollment
100 pts
Location
United States
Sponsor
Nova Southeastern University
NCT05349227 N/A
Recruiting
Comprehensive Outcomes for After Cancer Health
Condition
Ovarian Cancer
Enrollment
625 pts
Location
United States
Sponsor
Pack Health
NCT05947266 N/A
Recruiting
Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes
Condition
HIV Infection Primary
Enrollment
66 pts
Location
United States
Sponsor
Florida International Universi
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT07116746 Phase 2
Recruiting
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase ...
Condition
Gout
Enrollment
25 pts
Location
United States
Sponsor
Arthrosi Therapeutics
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT05952024 Phase 2
Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients ...
Condition
Diffuse Large B-Cell Lymphoma
Enrollment
80 pts
Location
United States, Brazil, Puerto Rico
Sponsor
AstraZeneca
NCT04923542 Phase 1, Phase 2
Recruiting
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cance...
Condition
Brain Metastases
Enrollment
31 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
NCT06682988 Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants ...
Condition
Advanced High-Grade Epithelial Ovarian
Enrollment
110 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT07189403 Phase 1
Recruiting
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Ca...
Condition
Advanced or Metastatic Adrenocortical Carcinoma
Enrollment
40 pts
Location
United States, France, United Kingdom
Sponsor
Daiichi Sankyo
NCT06378866 Phase 2
Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor ...
Condition
Recurrent Castration-Sensitive Prostate Carcinoma
Enrollment
532 pts
Location
United States
Sponsor
Mayo Clinic
NCT06532656 Phase 2, Phase 3
Recruiting
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
Condition
HIV-1-infection
Enrollment
75 pts
Location
United States, Argentina, Italy
Sponsor
Gilead Sciences
NCT00969111 N/A
Recruiting
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Fol...
Condition
Prostate Cancer
Enrollment
70 pts
Location
United States
Sponsor
Proton Collaborative Group
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals